P H Wiernik|A I Einzig - JoVE Visualize

Showing results (271-280 of 420) with videos related to

Pageof 42

Sort By:

Cancer|March 1, 1993

Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferonS Wadler, S Fell, H Haynes, et al.

Cancer|December 1, 1990

Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphomaJ P Dutcher, S L Marcus, H B Tanowitz, et al.

Cancer Treatment Reports|January 1, 1980

Phase I trial of pentamethylmelamine in patients with previously treated malignanciesD A Van Echo, D F Chiuten, M Whitacre, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanomaP H Wiernik, E L Schwartz, A Einzig, et al.

Leukemia|July 1, 1987

Mitoxantrone and ara-C in previously treated patients with acute myelogenous leukemiaP A Paciucci, J P Dutcher, J Cuttner, et al.

Cancer|March 15, 1991

13-cis-retinoic acid in the treatment of elderly patients with acute myeloid leukemia. A phase II pilot study of the Eastern Cooperative Oncology GroupZ B Kramer, L Boros, P H Wiernik, et al.

American Journal of Clinical Oncology|October 1, 1990

Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancerJ A Sparano, E L Schwartz, K M Salva, et al.

Leukemia|July 1, 1994

The immunophenotype of acute promyelocytic leukemia (APL): an ECOG studyE Paietta, J Andersen, R Gallagher, et al.

European Journal of Haematology|March 25, 1999

Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosisM D Colović, P H Wiernik, G M Janković, et al.

American Journal of Nephrology|January 1, 1991

Interstitial nephritis in a patient receiving adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cellsD A Feinfeld, V D'Agati, J P Dutcher, et al.

Pageof 42

Showing results (271-280 of 420) with videos related to

Sort By:

Pageof 42

Cancer|March 1, 1993

Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferonS Wadler, S Fell, H Haynes, et al.

Cancer|December 1, 1990

Disseminated strongyloidiasis with central nervous system involvement diagnosed antemortem in a patient with acquired immunodeficiency syndrome and Burkitts lymphomaJ P Dutcher, S L Marcus, H B Tanowitz, et al.

Cancer Treatment Reports|January 1, 1980

Phase I trial of pentamethylmelamine in patients with previously treated malignanciesD A Van Echo, D F Chiuten, M Whitacre, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanomaP H Wiernik, E L Schwartz, A Einzig, et al.

Leukemia|July 1, 1987

Mitoxantrone and ara-C in previously treated patients with acute myelogenous leukemiaP A Paciucci, J P Dutcher, J Cuttner, et al.

Cancer|March 15, 1991

13-cis-retinoic acid in the treatment of elderly patients with acute myeloid leukemia. A phase II pilot study of the Eastern Cooperative Oncology GroupZ B Kramer, L Boros, P H Wiernik, et al.

American Journal of Clinical Oncology|October 1, 1990

Phase II trial of etoposide, doxorubicin (Adriamycin), and cisplatin (EAP regimen) in advanced gastric cancerJ A Sparano, E L Schwartz, K M Salva, et al.

Leukemia|July 1, 1994

The immunophenotype of acute promyelocytic leukemia (APL): an ECOG studyE Paietta, J Andersen, R Gallagher, et al.

European Journal of Haematology|March 25, 1999

Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosisM D Colović, P H Wiernik, G M Janković, et al.

American Journal of Nephrology|January 1, 1991

Interstitial nephritis in a patient receiving adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cellsD A Feinfeld, V D'Agati, J P Dutcher, et al.

Pageof 42